Login / Signup
Shuhei Wada
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Depressive Symptoms
Social Support
Top Venues
Psychiatry and clinical neurosciences
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Shuhei Wada
,
Kunihiro Iwamoto
,
Norio Ozaki
Atezolizumab, an immune checkpoint inhibitor, caused precedent depressive symptoms related to limbic encephalitis.
Psychiatry and clinical neurosciences
76 (4) (2022)